Edwards Lifesciences (EW)
(Delayed Data from NYSE)
$86.43 USD
-1.58 (-1.80%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $86.49 +0.06 (0.07%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Price, Consensus and EPS Surprise
EW 86.43 -1.58(-1.80%)
Will EW be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for EW based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for EW
Factors Setting the Tone For Lantheus' (LNTH) Q1 Earnings
Edwards Lifesciences (EW) Q1 Earnings Top, 2024 Sales View Up
EW: What are Zacks experts saying now?
Zacks Private Portfolio Services
Compared to Estimates, Edwards Lifesciences (EW) Q1 Earnings: A Look at Key Metrics
Edwards Lifesciences (EW) Q1 Earnings and Revenues Top Estimates
Watch These 3 MedTech Stocks This Earnings Season: Beat or Miss?
Other News for EW
$1000 Invested In This Stock 15 Years Ago Would Be Worth $16,000 Today
Analysts Are Neutral on These Healthcare Stocks: Edwards Lifesciences (EW), Gilead Sciences (GILD)
Strong Q1 Performance and Positive Market Trends Reinforce Buy Rating for Edwards Lifesciences
Piper Sandler Sticks to Their Hold Rating for Edwards Lifesciences (EW)
Edwards Lifesciences (EW) Receives a Hold from Stifel Nicolaus